Carregant...
Radioimmunotargeting of Malignant Glioma by Monoclonal Antibody D2C7 Reactive Against Both Wild-Type and Variant III Mutant Epidermal Growth Factor Receptors
INTRODUCTION: Malignant glioma remains a significant therapeutic challenge and immunotherapeutics might be a beneficial approach for these patients. A monoclonal antibody (MAb) specific for multiple molecular targets could expand the treatable patient population and the fraction of tumor cells targe...
Guardat en:
| Autors principals: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3253233/ https://ncbi.nlm.nih.gov/pubmed/21958852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nucmedbio.2011.06.005 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|